The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-Chloro-3'-fluoro-5-methoxy-[1,1'-biphenyl]-4-yl)-N-(isoxazol-3-yl)-3-methyl-4-oxo-3,4-dihydrophthalazine-6-sulfonamide ID: ALA4097970
PubChem CID: 117741784
Max Phase: Preclinical
Molecular Formula: C25H18ClFN4O5S
Molecular Weight: 540.96
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(-c2cccc(F)c2)c(Cl)cc1-c1nn(C)c(=O)c2cc(S(=O)(=O)Nc3ccon3)ccc12
Standard InChI: InChI=1S/C25H18ClFN4O5S/c1-31-25(32)19-11-16(37(33,34)30-23-8-9-36-29-23)6-7-17(19)24(28-31)20-12-21(26)18(13-22(20)35-2)14-4-3-5-15(27)10-14/h3-13H,1-2H3,(H,29,30)
Standard InChI Key: HIEJKXMLHXPHRC-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
29.3463 -6.8202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.8221 -6.1560 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.0090 -6.0760 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1026 -4.9379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8148 -5.3385 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5362 -6.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5400 -7.3728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9436 -6.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2317 -6.1386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9554 -7.3568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2525 -7.7686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2576 -8.5787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9640 -8.9833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6670 -8.5715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6635 -7.7552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3680 -7.3412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0775 -7.7489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7816 -7.3356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7757 -6.5176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0599 -6.1146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3588 -6.5303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4797 -6.1026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0813 -8.5661 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.3754 -8.9780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1874 -6.5083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8909 -6.0940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8840 -5.2760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1677 -4.8740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4671 -5.2906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1574 -4.0569 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.0508 -5.2975 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.0109 -4.1276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2097 -3.9666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8090 -4.6789 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.3627 -5.2799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9680 -9.8005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5519 -8.9908 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 2 1 0
2 6 1 0
6 7 2 0
7 11 1 0
10 8 1 0
8 9 2 0
9 6 1 0
10 11 2 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
17 23 1 0
23 24 1 0
22 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 22 1 0
28 30 1 0
20 31 1 0
4 32 1 0
32 33 2 0
33 34 1 0
34 35 1 0
35 4 2 0
13 36 1 0
12 37 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 540.96Molecular Weight (Monoisotopic): 540.0670AlogP: 4.86#Rotatable Bonds: 6Polar Surface Area: 116.32Molecular Species: ACIDHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 5.73CX Basic pKa: ┄CX LogP: 4.64CX LogD: 3.77Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.33Np Likeness Score: -1.58
References 1. Weiss MM, Dineen TA, Marx IE, Altmann S, Boezio A, Bregman H, Chu-Moyer M, DiMauro EF, Feric Bojic E, Foti RS, Gao H, Graceffa R, Gunaydin H, Guzman-Perez A, Huang H, Huang L, Jarosh M, Kornecook T, Kreiman CR, Ligutti J, La DS, Lin MJ, Liu D, Moyer BD, Nguyen HN, Peterson EA, Rose PE, Taborn K, Youngblood BD, Yu V, Fremeau RT.. (2017) Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities., 60 (14): [PMID:28287723 ] [10.1021/acs.jmedchem.6b01851 ]